These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 14710355

  • 21. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH.
    Zhonghua Yi Xue Za Zhi; 2007 Jun 05; 87(21):1506-9. PubMed ID: 17785094
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Conditional deletion of insulin-like growth factor-I receptor in prostate epithelium.
    Sutherland BW, Knoblaugh SE, Kaplan-Lefko PJ, Wang F, Holzenberger M, Greenberg NM.
    Cancer Res; 2008 May 01; 68(9):3495-504. PubMed ID: 18451178
    [Abstract] [Full Text] [Related]

  • 26. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
    Lu M, Arrick BA.
    Oncogene; 2000 Dec 14; 19(54):6351-60. PubMed ID: 11175350
    [Abstract] [Full Text] [Related]

  • 27. BRCA1 signals ARF-dependent stabilization and coactivation of p53.
    Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, el-Deiry WS.
    Oncogene; 1999 Nov 11; 18(47):6605-14. PubMed ID: 10597265
    [Abstract] [Full Text] [Related]

  • 28. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
    DelloRusso C, Welcsh PL, Wang W, Garcia RL, King MC, Swisher EM.
    Mol Cancer Res; 2007 Jan 11; 5(1):35-45. PubMed ID: 17259345
    [Abstract] [Full Text] [Related]

  • 29. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B, Faniello MC, Baudi F, Crugliano T, Di Sanzo M, Cuda G, Costanzo F, Venuta S.
    Oncol Rep; 2006 Oct 11; 16(4):811-5. PubMed ID: 16969499
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice.
    Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH.
    Cell Biol Int; 2007 May 11; 31(5):500-7. PubMed ID: 17196841
    [Abstract] [Full Text] [Related]

  • 31. Cytoplasmic mutant p53 increases Bcl-2 expression in estrogen receptor-positive breast cancer cells.
    Pratt MA, White D, Kushwaha N, Tibbo E, Niu MY.
    Apoptosis; 2007 Apr 11; 12(4):657-69. PubMed ID: 17252199
    [Abstract] [Full Text] [Related]

  • 32. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
    Jones RA, Campbell CI, Petrik JJ, Moorehead RA.
    Mol Cancer Res; 2008 May 11; 6(5):819-28. PubMed ID: 18505926
    [Abstract] [Full Text] [Related]

  • 33. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X, Yue P, Khuri FR, Sun SY.
    Cancer Res; 2004 Aug 01; 64(15):5078-83. PubMed ID: 15289308
    [Abstract] [Full Text] [Related]

  • 34. Regulation of insulin-like growth factor II P3 promotor by p53: a potential mechanism for tumorigenesis.
    Zhang L, Kashanchi F, Zhan Q, Zhan S, Brady JN, Fornace AJ, Seth P, Helman LJ.
    Cancer Res; 1996 Mar 15; 56(6):1367-73. PubMed ID: 8640827
    [Abstract] [Full Text] [Related]

  • 35. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H, Pelzer AM, Kiang DT, Yee D.
    Cancer Res; 2007 Jan 01; 67(1):391-7. PubMed ID: 17210722
    [Abstract] [Full Text] [Related]

  • 36. Targeting gene expression to tumor cells with loss of wild-type p53 function.
    Zhu J, Gao B, Zhao J, Balmain A.
    Cancer Gene Ther; 2000 Jan 01; 7(1):4-12. PubMed ID: 10678350
    [Abstract] [Full Text] [Related]

  • 37. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene.
    Casey G, Lo-Hsueh M, Lopez ME, Vogelstein B, Stanbridge EJ.
    Oncogene; 1991 Oct 01; 6(10):1791-7. PubMed ID: 1923504
    [Abstract] [Full Text] [Related]

  • 38. The insulin-like growth factor-I receptor as an oncogene.
    Werner H, Bruchim I.
    Arch Physiol Biochem; 2009 May 01; 115(2):58-71. PubMed ID: 19485702
    [Abstract] [Full Text] [Related]

  • 39. BRCA1 regulation of transcription.
    Rosen EM, Fan S, Ma Y.
    Cancer Lett; 2006 May 18; 236(2):175-85. PubMed ID: 15975711
    [Abstract] [Full Text] [Related]

  • 40. The effects of BRCA1 missense variants V1804D and M1628T on transcriptional activity.
    Ostrow KL, McGuire V, Whittemore AS, DiCioccio RA.
    Cancer Genet Cytogenet; 2004 Sep 18; 153(2):177-80. PubMed ID: 15350310
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.